INVE Technologies vs TransAct Technologies
INVE and TACT side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INVE and TACT compare
INVE Technologies is the larger company, worth 1.3 times as much as TransAct Technologies ($64.7M against $50.4M).
TransAct Technologies grew revenue faster over the last twelve months (10.5% versus 3.1% for INVE Technologies).
TransAct Technologies keeps more of each dollar of sales as profit, with a net margin of −0.75% compared with −62.9% at INVE Technologies.
TransAct Technologies scores higher on the StockData Score (10 against 7 for INVE Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INVE | TACT |
|---|---|---|
| Size and price | ||
| Market cap | $64.7M | $50.4M |
| Share price | $2.67 | $4.88 |
| Change, 1 year | −27.6% | 13.0% |
| Change, 5 years | −88.5% | −56.4% |
| Beta (5Y) | 1.37 | 0.89 |
| Employees | 155 | 103 |
| StockData Score | ||
| Total score | 7 | 10 (better) |
| Valuation score | 1 | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.7× | 1.0× (better) |
| P/B | 0.5× (better) | 1.5× |
| EV/EBITDA | – | 156× |
| P/FCF | – | 9.6× |
| FCF yield | −14.2% | 10.4% (better) |
| Fair value | – | $4.02 |
| Margin of safety | – | −21.3% |
| Growth | ||
| Revenue growth (TTM) | 3.1% | 10.5% (better) |
| Revenue growth, 5Y average | −24.4% | 11.0% (better) |
| Net income growth (TTM) | −120% | – |
| EPS growth (TTM) | −121% | – |
| Profitability | ||
| Gross margin | 15.9% | 49.6% (better) |
| Operating margin | −82.4% | −0.80% (better) |
| Net margin | −62.9% | −0.75% (better) |
| FCF margin | −37.9% | 9.9% (better) |
| Return on equity | −10.9% | −1.3% (better) |
| Return on invested capital | −103% | −2.5% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 20.35 (better) | 2.65 |
| Altman Z-score | 2.24 | 3.36 (better) |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 40.8% | 38.0% |
| Held by insiders | 31.9% | 62.0% |
| Insider net buying, 12 months | – | $351K |
| Short interest, % of float | 1.1% | 0.70% |
Go deeper
- INVE stock overview
- INVE income statement
- INVE valuation and score
- TACT stock overview
- TACT income statement
- TACT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.